•  
  •  
  •  
  •  

2026-05-21 04:51:41

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • GRSE Launches Next-Gen OPV: Crafted for Vigilance, Built for Victory
  • Muthoot Finance Ranked India's No. 1 Most Trusted Financial Services Brand for 10th Consecutive Year
  • Ampere Magnus G Max by Greaves Electric Mobility Wins 'Family Scooter of the Year' at Times Drive Auto Summit and Awards 2026
  • Eris delivers 11% yoy growth in Domestic Formulations with 37% EBIDTA margin in FY26
  • DevX - Standalone Revenue from Operations grew 34.3% YoY in FY26

Keywords Selected:  APIFacility

Stock Report

  • Supriya Lifescience Receives USFDA EIR with VAI Classification for Maharashtra API Facility
  • Ipca Laboratories Ltd receives 3 observations from USFDA for API facility at Tarapur
  • Alembic Pharmaceuticals Ltd receives EIR from USFDA for facility at Panelav
  • Apitoria Pharma Pvt Ltd receives 5 observations from USFDA for API facility
  • Concord Biotech Limited completes EUGMP inspection at its API facility
  • Concord Biotech Ltd successfully completes Russian GMP insepction at its API facility
  • Concord Biotech Ltd announces successful completion EU GMP inspection at its API facility
  • Concord Biotech Limited receives EIR from USFDA for API facility at Dholka
  • Unichem Laboratories Ltd receives Form 483 from USFDA with 3 observations for Roha API facility
  • Zydus receives EIR for the API manufacturing facility at Dabhasa
  • USFDA Inspection at Concord Biotech Ltd's API facility at Dholka
  • Nectar Lifesciences Limited receives 7 observations from EDQM for API facility
  • Unichem Laboratories Ltd receives 4 observations from USFDA for Pithampur API facility
  • Senores Pharmaceuticals begins operations at greenfield API facility
  • USFDA inspection at Emcure Pharmaceuticals Ltd's API facility
  • Aarti Drugs Ltd receives EIR from USFDA for Tarapur API facility
  • Bajaj Healthcare Ltd's API facility receives approval from TGA, Australia
  • Shivalik Rasayan Limited gets USFDA approval for API facility at Dahej
  • Apitoria Pharma Pvt Ltd gets Form 483 with 10 observations from US FDA
  • Dr. Reddy's Laboratories Limited gets Form 483 from USFDA with 4 observations for API facility
  • Shivalik Rasayan Ltd's API facility gets 7 observations from USFDA
  • Concord Biotech Limited receives EUGMP certificate for Dholka facility
  • Zydus receives Post Application Action Letter for the USFDA cGMP nd Pre-Approval Inspection at the Ahmedabad API facility
  • EDQM conducts GMP inspection of SMS Pharmaceuticals Ltd's API facility

Latest Post

  • GRSE Launches Next-Gen OPV: Crafted for Vigilance, Built for Victory
  • Muthoot Finance Ranked India's No. 1 Most Trusted Financial Services Brand for 10th Consecutive Year
  • Ampere Magnus G Max by Greaves Electric Mobility Wins 'Family Scooter of the Year' at Times Drive Auto Summit and Awards 2026
  • Eris delivers 11% yoy growth in Domestic Formulations with 37% EBIDTA margin in FY26
  • DevX - Standalone Revenue from Operations grew 34.3% YoY in FY26


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025